Liancheng Zhu | Medicine and Dentistry | Best Researcher Award

Published on 02/04/2025 by Global Academic Awards

Prof. Liancheng Zhu | Medicine and Dentistry | Best Researcher Award

Prof. Liancheng Zhu , Medicine and Dentistry , China Medical University, China

Dr. Zhu Liancheng is a highly respected professor of Obstetrics and Gynecology at Shengjing Hospital of China Medical University in Shenyang, Liaoning Province, China. He earned his doctor’s degree in Obstetrics and Gynecology from China Medical University.Dr. Zhu has a deep commitment to advancing women’s health through his expertise in gynecologic oncology, particularly in ovarian and endometrial cancers. With a distinguished career in clinical practice and research, he has contributed significantly to the study of molecular markers, gene expression profiles, and cancer treatment strategies in gynecological malignancies. His work has been published in leading international medical journals, and his research has garnered attention for its impact on cancer prognostication and therapeutic approaches. Dr. Zhu’s ongoing research continues to influence gynecologic oncology, focusing on improving cancer detection, prognosis, and treatment in women worldwide.

Publication Profile

Scopus

Academic Background🎓

Dr. Zhu Liancheng completed his medical education at China Medical University, Liaoning Province, China, where he earned his Doctor’s degree in Obstetrics and Gynecology in 2015. His academic foundation in gynecology was followed by extensive training and research in the field of women’s reproductive health, particularly focusing on gynecologic oncology. Dr. Zhu’s education has provided him with the expertise to explore the molecular and clinical aspects of gynecologic cancers, such as ovarian and endometrial cancers. He has undertaken advanced studies in cancer genomics, tumor markers, and the molecular mechanisms behind chemoresistance, with particular emphasis on gene expression analysis. This rigorous academic background has enabled him to make meaningful contributions to both clinical practice and the advancement of medical knowledge in the field of obstetrics and gynecology. His work has led to multiple publications and a broad recognition in the field of gynecologic cancer research.

Professional Background🏅

Dr. Zhu Liancheng is a professor in Obstetrics and Gynecology at Shengjing Hospital of China Medical University, where he has gained significant experience in both clinical practice and research. His clinical expertise includes diagnosing and treating complex gynecological conditions, particularly cancers such as ovarian, endometrial, and cervical cancers. He has contributed to the development of treatment protocols and strategies aimed at improving patient outcomes in gynecologic oncology. Dr. Zhu has also been deeply involved in translational research, studying molecular biomarkers and gene expression profiles that influence cancer progression and chemoresistance. His research has provided insights into the genetic mechanisms behind cancer prognosis and the development of targeted therapies. His role as a mentor for medical students, residents, and researchers further underscores his leadership in advancing gynecologic oncology. With a strong clinical and academic foundation, Dr. Zhu continues to make a significant impact on both patient care and scientific advancements.

Awards and Honors🏆

Dr. Zhu Liancheng’s outstanding contributions to the field of Obstetrics and Gynecology, particularly in gynecologic oncology, have earned him recognition from both national and international medical communities. Although specific awards are not listed, his extensive publication record, including numerous influential articles in leading medical journals, underscores his recognition as an expert in the field. His research on ovarian and endometrial cancers, gene expression profiles, and treatment resistance has been widely cited, demonstrating the impact of his work. Dr. Zhu has been invited to present at various national and international conferences, further solidifying his status as a thought leader in gynecologic oncology. Additionally, his role in advancing clinical practices and contributing to the development of prognostic tools for cancer patients reflects the high regard in which he is held by his peers. Dr. Zhu’s work continues to influence the future of gynecologic cancer research and treatment.

Research Focus🔬

Dr. Zhu Liancheng’s research primarily focuses on the molecular mechanisms behind gynecological cancers, with particular emphasis on ovarian and endometrial cancers. His work aims to identify novel biomarkers and genetic profiles that can predict cancer prognosis, progression, and response to therapy. Through gene expression analysis and the study of various molecular markers, Dr. Zhu seeks to enhance the understanding of how these cancers develop and metastasize, particularly focusing on chemoresistance and the role of tumor-associated genes. His research has contributed to identifying potential therapeutic targets, such as human epididymis protein 4 (HE4) and α1,2-fucosyltransferase (FUT1), which may offer new approaches to cancer treatment. Dr. Zhu’s work in gynecologic oncology is essential for improving the survival rates and quality of life for women with ovarian and endometrial cancers. His research also bridges the gap between laboratory findings and clinical applications, offering new hope for more effective treatment strategies in gynecological oncology.

Publication Top Notes

Integration of scRNA-seq and bulk RNA-seq to reveal the association and potential molecular mechanisms of metabolic reprogramming regulated by lactylation and chemotherapy resistance in ovarian cancer

Erratum: Retraction notice to “Downregulation of Rab23 inhibits proliferation, invasion, and metastasis of human ovarian cancer”

Corrigendum: SERPIND1 affects the malignant biological behavior of epithelial ovarian cancer via the PI3K/AKT pathway: a mechanistic study

Ferroptosis: mechanism, immunotherapy and role in ovarian cancer

Coordination of Single-cell and Bulk RNA Sequencing to Construct a Cuproptosis-related Gene Prognostic Index for Endometrial Cancer Prognosis, Immune Microenvironment Infiltration, and Immunotherapy Treatment Options

Citations: 2

Identification of a pyroptosis-related long non-coding RNA Signature for prognosis and its related ceRNA regulatory network of ovarian cancer

Citations: 5

Prognosis, Immune Microenvironment Infiltration and Immunotherapy Response in Clear Cell Renal Cell Carcinoma Based on Cuproptosis-related Immune Checkpoint Gene Signature

Citations: 2

Conclusion

Dr. Zhu Liancheng is highly deserving of the “Best Researcher Award” due to his outstanding and impactful research in the field of gynecologic oncology. His contributions to understanding the molecular underpinnings of ovarian and endometrial cancers, particularly his work on gene expression profiles and chemotherapy resistance, have had a profound impact on the field. His research not only furthers the understanding of cancer biology but also provides insights that could lead to better treatments and improved survival rates for women with these cancers. Dr. Zhu’s combination of clinical expertise, innovative research, and dedication to advancing women’s health positions him as a leader in his field. The breadth and depth of his work, coupled with his extensive publication record, make him a deserving candidate for this prestigious recognition. His influence on the future of gynecologic oncology is immense, and he continues to inspire and lead groundbreaking research efforts in the medical community.

Nazim Uzzaman | Medicine and Dentistry | Best Researcher Award | 12753

Published on 06/01/202506/01/2025 by Global Academic Awards

Dr. Nazim Uzzaman | Medicine and Dentistry | Best Researcher Award

PhD Candidate at The University of Edinburgh, United Kingdom

Dr. Nazim Uzzaman is a researcher and academic with a focus on chronic respiratory diseases, including asthma, COPD, pulmonary rehabilitation, and digital health. He is currently pursuing a PhD at The University of Edinburgh and has a Master of Public Health from American International University–Bangladesh. Dr. Uzzaman has contributed to 17 research articles, with 7 as the lead author, and has been involved in 8 research projects, serving as Principal Investigator in two. His expertise includes systematic reviews, mixed-methods studies, focused ethnography, and implementation research. Dr. Uzzaman has received several awards, including Best Oral Presentation at the IPCRG World Conference and Best Scientific Research Poster at the PCRS Respiratory Conference. He is an active member of the European Respiratory Society and the International Primary Care Respiratory Group. Additionally, he serves as a peer reviewer for prestigious journals, further cementing his reputation in the research community.

Professional Profile :

Google Scholar
ORCID Profile

Education:

Dr. Nazim Uzzaman has a robust academic background in medicine and public health. He completed his Bachelor of Medicine, Bachelor of Surgery (MBBS) at Rajshahi Medical College in Bangladesh in 2010. Following this, he pursued a Master of Public Health (MPH) at American International University–Bangladesh, graduating in 2017. Currently, Dr. Uzzaman is a PhD candidate at The University of Edinburgh, where he is focusing on applied respiratory health research, with his thesis already submitted. His academic journey reflects a commitment to advancing his knowledge in both clinical medicine and public health, particularly in the area of chronic respiratory diseases. This combination of clinical and public health education provides him with a unique perspective on respiratory health research, equipping him to address complex healthcare challenges. Dr. Uzzaman’s academic achievements demonstrate his dedication to both research and practical applications in the medical field.

Professional Experience:

Dr. Nazim Uzzaman has extensive professional experience in both clinical and academic settings. He is currently a PhD student at The University of Edinburgh, where he is conducting research in respiratory applied health, focusing on chronic respiratory diseases such as asthma, COPD, and pulmonary rehabilitation. Dr. Uzzaman also serves as a part-time tutor for the Master of Family Medicine program and as a dissertation supervisor for the Master of Public Health program at the university. In addition, he is a Trial Manager for the Bangladesh site of a respiratory health project, where he oversees research operations. Previously, Dr. Uzzaman worked at icddr,b in Bangladesh, progressing from Clinical Fellow to Medical Officer, Clinical Trainer, and Training Physician, contributing to healthcare delivery and medical training. He has also worked as a General Practitioner at Green and Green Medical Services in Bangladesh, gaining hands-on experience in primary care and patient management.

Research Interest:

Dr. Nazim Uzzaman’s research interests lie primarily in the field of chronic respiratory diseases, with a focus on asthma, COPD, and pulmonary rehabilitation. He is particularly interested in exploring innovative solutions to improve patient outcomes through digital health technologies. His expertise spans systematic reviews, mixed-methods studies, focused ethnography, and implementation research, which he utilizes to assess and enhance healthcare interventions. Dr. Uzzaman’s work aims to bridge the gap between clinical practice and research, emphasizing the application of evidence-based strategies to improve care for individuals with respiratory conditions. Additionally, his research investigates the effectiveness of pulmonary rehabilitation programs and the integration of digital health tools to support self-management in patients with chronic respiratory diseases. His interdisciplinary approach and commitment to understanding the lived experiences of patients position him as a key contributor to advancing respiratory health research, with the ultimate goal of improving public health outcomes.

Award and Honor:

Dr. Nazim Uzzaman has received several prestigious awards and honors in recognition of his outstanding contributions to respiratory health research. He was awarded the Best Oral Presentation at the IPCRG World Conference in 2021, highlighting his ability to effectively communicate complex research findings. Additionally, he received the Best Scientific Research Poster award at the PCRS Respiratory Conference in the UK in 2019, further emphasizing his excellence in presenting innovative research in the field. Dr. Uzzaman was also honored with the RESPIRE Fellowship (2019–2020), a prestigious recognition that supports early-career researchers in global respiratory health. His academic and research accomplishments have been consistently acknowledged, with his work being featured in respected journals and conferences. These accolades reflect his commitment to advancing knowledge in chronic respiratory diseases and his growing influence within the global respiratory research community.

Conclusion:

Dr. Nazim Uzzaman has demonstrated a strong commitment to advancing research in respiratory health, particularly focusing on chronic diseases like asthma, COPD, and pulmonary rehabilitation, along with the integration of digital health solutions. With a robust academic background, including a PhD studentship at The University of Edinburgh and a Master of Public Health, Dr. Uzzaman has contributed significantly to the field through 17 published research articles and involvement in several high-impact projects. His leadership as Principal Investigator and Co-Investigator, coupled with his expertise in systematic reviews, mixed-methods studies, and implementation research, underscores his capability in driving impactful health research. Recognized for his scholarly work with multiple awards, including Best Oral Presentation and Best Scientific Research Poster, Dr. Uzzaman continues to make valuable contributions to the academic community. His ongoing work and professional involvement in global respiratory health organizations position him as a promising leader in clinical academic research.

Publication Top Notes :

Title: Systematic review of clinical effectiveness, components, and delivery of pulmonary rehabilitation in low-resource settings
Authors: GMM Habib, R Rabinovich, K Divgi, S Ahmed, SK Saha, S Singh, A Uddin, MN Uzzaman, …
Year: 2020
Citations: 46
Title: Effectiveness of home-based pulmonary rehabilitation: systematic review and meta-analysis
Authors: MN Uzzaman, D Agarwal, SC Chan, JP Engkasan, GMM Habib, …
Year: 2022
Citations: 40
Title: Continuing professional education for general practitioners on chronic obstructive pulmonary disease: feasibility of a blended learning approach in Bangladesh
Authors: MN Uzzaman, T Jackson, A Uddin, N Rowa-Dewar, MJ Chisti, …
Year: 2020
Citations: 32
Title: Correlates of climate variability and dengue fever in two metropolitan cities in Bangladesh
Authors: MZ Islam, S Rutherford, D Phung, MN Uzzaman, S Baum, MM Huda, …
Year: 2018
Citations: 30
Title: Engaging with stakeholders in a research programme to promote implementation of pulmonary rehabilitation in Bangladesh: Challenges and opportunities
Authors: GMM Habib, MN Uzzaman, P Malik, R Rabinovich, A Uddin, SMR Alam, …
Year: 2020
Citations: 12
Title: Clinical effectiveness and components of home-pulmonary rehabilitation for people with chronic respiratory diseases: a systematic review protocol
Authors: MN Uzzaman, SC Chan, RH Shunmugam, JP Engkasan, D Agarwal, …
Year: 2021
Citations: 9
Title: Prevalence of type 2 diabetes mellitus among urban Bihari communities in Dhaka, Bangladesh: a cross-sectional study in a minor ethnic group
Authors: M Asaduzzaman, S Chowdhury, JH Shahed, MAH Kafi, MN Uzzaman, …
Year: 2018
Citations: 9
Title: Characteristics of Rotavirus, ETEC, and Vibrio Cholerae among under 2-year children attending an urban diarrheal disease hospital in Bangladesh
Authors: MHR Sarker, M Moriyama, MM Rahman, SK Das, MN Uzzaman, J Das, …
Year: 2021
Citations: 8
Title: Village doctors: a national telephone survey of Bangladesh’s lay medical practitioners
Authors: O Muurlink, N Uzzaman, RJ Boorman, S Binte Kibria, T Best, …
Year: 2023
Citations: 4
Title: Beyond the regulatory radar: knowledge and practices of rural medical practitioners in Bangladesh
Authors: H Sujon, MHR Sarker, A Uddin, S Banu, MR Islam, MR Amin, MS Hossain, …
Year: 2023
Citations: 3
Title: Asynchronous digital health interventions for reviewing asthma: A mixed-methods systematic review protocol
Authors: MN Uzzaman, V Hammersley, K McClatchey, J Sheringham, GMM Habib, …
Year: 2023
Citations: 3
Title: Professional development of health researchers during the COVID-19 pandemic: challenges and prospects of synchronous online learning
Authors: H Sujon, MN Uzzaman, S Banu, MR Islam, M Asaduzzaman, A Ahmed, …
Year: 2022
Citations: 3
Title: Improving physicians’ capacity for chronic obstructive pulmonary disease care through blended e-learning: a pilot study in Bangladesh
Authors: MN Uzzaman, S Banu, GMM Habib, AHME Hossain, MJ Kabir, MR Karim, …
Year: 2018
Citations: 3
Title: Neonatal pneumonia in a rural primary care hospital in Bangladesh: prevalence, validation of clinical features and their outcome
Authors: MN Uzzaman, MAF Khan, T Ahmed, MHR Sarker, S Yeasmin, KN Saqeeb, …
Year: 2016
Citations: 1
Title: Effectiveness and Acceptability of Asynchronous Digital Health in Asthma Care: Mixed Methods Systematic Review
Authors: N Uzzaman, V Hammersley, K McClatchey, J Sheringham, D Singh, …
Year: 2024
Citations: N/A (Future publication)
Title: Exploring the perceptions of patients with chronic respiratory diseases and their insights into pulmonary rehabilitation in Bangladesh
Authors: GMM Habib, N Uzzaman, R Rabinovich, S Akhter, M Ali, M Sultana, …
Year: 2024
Citations: N/A (Future publication)
Title: Characteristics of pulmonary rehabilitation programmes and their effects on exercise capacity and quality of life in patients with interstitial lung diseases: a systematic …
Authors: J Jimenez, F Tahirah, N Uzzaman, R Hisham, N Zawani, H Pinnock, …
Year: 2023
Citations: N/A (Future publication)
Title: Asynchronous digital health interventions (aDHI) for reviewing asthma: a mixed-methods systematic review
Authors: N Uzzaman, V Hammersley, K McClatchey, J Sheringham, M Habib, …
Year: 2023
Citations: N/A (Future publication)
Title: Changing Water-Sanitation Determinants of Cholera over Two Decades in Bangladesh
Authors: MHR Sarker, SK Das, H Sujon, M Moriyama, MM Rahman, MN Uzzaman, …
Year: 2023
Citations: N/A (Future publication)
Title: Feasibility study of home-based pulmonary rehabilitation (PR) in Bangladesh
Authors: GMM Habib, R Rabinovich, N Uzzaman, K Nahar, S Akter, H Pinnock
Year: 2022
Citations: N/A (Future publication)

Carmen Lefaucheur | Dentistry Award | Excellence in Research

Published on 13/09/202416/09/2024 by Global Academic Awards

Prof Dr. Carmen Lefaucheur | Dentistry Award | Excellence in Research

Prof Dr. Carmen Lefaucheur, Hopital Saint Louis, France

Prof. Dr. Carmen Lefaucheur is a highly accomplished nephrologist and expert in kidney transplantation. She serves as the Head of the Department of Nephrology and Kidney Transplantation at Saint-Louis Hospital, Paris, and is a Professor of Nephrology at Université Paris Cité. Additionally, she is the Medical Director of the Paris Institute for Transplantation & Organ Regeneration (PITOR) and has an extensive background in personalized medicine for chronic diseases and organ transplantation. She holds multiple prestigious positions in international scientific committees and has received numerous awards, including the Paul I. Terasaki Clinical Science Award.

Publication profile

Orcid

Research Leadership:

Dr. Lefaucheur is the Head of the Department of Nephrology and Kidney Transplantation at Saint-Louis Hospital and the Medical Director of the Paris Institute for Transplantation & Organ Regeneration (PITOR). Her leadership in these roles highlights her impact in advancing research and clinical practice in nephrology and transplantation.

Research Excellence:

She has received numerous prestigious awards, including the Paul I. Terasaki Clinical Science Award and the European Society of Organ Transplantation Award, recognizing her contributions to the field. Her research publications are highly cited, with significant papers in top-tier journals such as Nature Medicine.

Grant Leadership:

Dr. Lefaucheur coordinates major research grants, including the RO1 Grant for biomarkers and digital pathology, indicating her pivotal role in funding and leading cutting-edge research.

International Influence:

Her extensive involvement with international committees and scientific societies, such as the European Society of Organ Transplantation (ESOT) and the American Society of Transplantation (AST), demonstrates her influence and recognition in the global research community.

Educational Contributions:

Her roles in organizing scientific meetings and her invitations to speak at major international congresses further underline her leadership and expertise.

Publication Top Notes

Complement-Activating Anti-HLA Antibodies in Kidney Transplantation: Allograft Gene Expression Profiling and Response to Treatment

From Humoral Theory to Performant Risk Stratification in Kidney Transplantation

Conclusion

Dr. Lefaucheur embodies the qualities of excellence in research and would be a strong candidate for this award.

Gagan Mathur | Medicine and Dentistry Award | Best Researcher Award

Published on 29/08/202429/08/2024 by Global Academic Awards

Assoc Prof Dr. Gagan Mathur | Medicine and Dentistry Award | Best Researcher Award

Assoc Prof Dr. Gagan Mathur, University of California Irvine, United States

Assoc Prof Dr. Gagan Mathur: Candidate for Best Researcher Award Evaluation

Publication profile

Google Scholar

Employment History

Dr. Gagan Mathur is a highly experienced professional with a strong background in transfusion medicine and clinical pathology. Since December 2022, he has served as the Medical Director of Transfusion Medicine-Blood Bank at the University of California Irvine School of Medicine, where he also holds the role of Associate Program Director of the Pathology Residency Program. He has previously held prominent positions at the Children’s Hospital Los Angeles and Saint Luke’s Health System in Kansas City, demonstrating his leadership and expertise in managing complex medical and educational settings.

Post-Graduate Training and Education

Dr. Mathur’s rigorous academic background includes a fellowship in Transfusion Medicine/Blood Banking and a residency in Clinical Pathology at the University of Iowa Hospitals & Clinics. He also holds an MBA from the University of Iowa, which complements his medical expertise with business acumen. His foundational medical education was completed at Dr. S.N. Medical College in India.

Certifications and Licensure

Dr. Mathur is board-certified in both Transfusion Medicine/Blood Banking and Clinical Pathology by the American Board of Pathology. He holds medical licenses in California and previously held licenses in Missouri, Kansas, and Iowa. His certification as a Certified Physician Executive underscores his commitment to leadership in healthcare.

Awards and Distinctions

Dr. Mathur has been recognized for his contributions to medicine with numerous accolades, including being named a Top Pathologist by Best in California Magazine in 2023 and a multiple nominee for the Orange County Physician of Excellence award. His early recognition includes the Paul E. Strandjord Young Investigator Award and an Outstanding Reviewer award from a leading scientific journal.

Teaching and Mentoring

Dr. Mathur is actively involved in teaching and mentoring the next generation of medical professionals. He serves as an Associate Program Director and Chair of the Clinical Competency Committee in the Pathology Residency Program at UC Irvine. He also contributes as a faculty member in various transfusion medicine and blood banking courses for medical students, residents, fellows, and clinical laboratory scientist students.

Publication Top Notes

Four postmortem case reports with quantitative detection of the synthetic cannabinoid, 5F-PB-22 (Journal of Analytical Toxicology) – Cited by 206, 2014 🧪📊
Antibody testing for COVID-19: can it be used as a screening tool in areas with low prevalence? (American Journal of Clinical Pathology) – Cited by 90, 2020 🦠🔬
High clinical suspicion of donor‐derived disease leads to timely recognition and early intervention to treat solid organ transplant‐transmitted lymphocytic choriomeningitis virus (Transplant Infectious Disease) – Cited by 29, 2017 🏥🦠
Use of a data warehouse at an academic medical center for clinical pathology quality improvement, education, and research (Journal of Pathology Informatics) – Cited by 25, 2015 📈🧑‍💻
Clinical profile and mortality among novel influenza A (H1N1) infected patients: 2009-2010 Jodhpur, Rajasthan pandemic (Journal of the Association of Physicians of India) – Cited by 25, 2013 🏥🌍
Antibody testing for COVID-19 (American Journal of Clinical Pathology) – Cited by 7, 2020 🦠🧬
Factors influencing platelet clumping during peripheral blood hematopoietic stem cell collection (Transfusion) – Cited by 7, 2017 🩸🔬
A clinico-epidemiologic study of neurologic associations and factors related to speech and language delay (National Journal of Community Medicine) – Cited by 7, 2012 🧠🗣️
Solutions to technical challenges during therapeutic plasma exchange using the Spectra Optia on a 4 kilogram neonate (Transfusion and Apheresis Science) – Cited by 5, 2018 🍼🩸
Streamlined sign-out of capillary protein electrophoresis using middleware and an open-source macro application (Journal of Pathology Informatics) – Cited by 5, 2014 🧬💻
A case for a national registry of red blood cell antibodies (Vox Sanguinis) – Cited by 4, 2022 🩸🧾
Predicting changes in hemoglobin S after simple transfusion using complete blood counts (Transfusion) – Cited by 3, 2018 🩸🧪
A case cluster of lymphocytic choriomeningitis virus transmitted via organ transplantation (Transplantation) – Cited by 2, 2014 🦠🏥

Conclusion

Assoc Prof Dr. Gagan Mathur’s extensive experience, academic background, and leadership roles make him a strong candidate for the Best Researcher Award. His contributions to transfusion medicine, combined with his teaching and mentoring roles, demonstrate a commitment to advancing medical science and education. His recognition by peers and multiple accolades further support his suitability for this prestigious award

Jianglan Long | Medicine and Dentistry | Best Innovation Award

Published on 10/06/202410/06/2024 by Global Academic Awards

Jianglan Long | Medicine and Dentistry | Best Innovation Award

Dr Jianglan Long,Beijing Institute of Clinical Pharmacy, Beijing Friendship Hospital, Capital Medical University,China

Dr. Jianglan Long is a dedicated Researcher Intern at Beijing Institute of Clinical Pharmacy, affiliated with Beijing Friendship Hospital and Capital Medical University. Specializing in intelligent molecular diagnostics and drug intervention mechanisms for pre-diabetes and type 2 diabetes, Dr. Long has published several impactful papers. Notable works include studies in International Journal of Biological Macromolecules (2024) on innovative diabetes treatments, and contributions to Diabetes Obesity & Metabolism (2024) on predictive biomarker profiling. Dr. Long is a pioneer in developing integrated diagnostic tools and advancing diabetes treatment in China. 🌟🔬📚

Publication profile

Scopus

Academic and Professional Background

Dr. Jianglan Long is a prominent researcher based at the Beijing Institute of Clinical Pharmacy, affiliated with Beijing Friendship Hospital, Capital Medical University. His primary focus lies in the exploration of intelligent molecular diagnosis and drug intervention mechanisms for prediabetes and type 2 diabetes. Dr. Jianglan Long has made significant contributions to this field, evidenced by his publications in reputable journals such as the International Journal of Biological Macromolecules (2024), Diabetes Obesity & Metabolism (2024), Clinical and Translational Medicine (2021), BMC Endocrine Disorders (2020), and Rapid Communications in Mass Spectrometry (2020), where he served as the first author.

Research focus

Category: Research Focus on Intelligent Molecular Diagnosis and Drug Intervention for Diabetes

Jianglan Long’s research centers on advancing the field of intelligent molecular diagnostics and drug interventions for pre-diabetes and type 2 diabetes. Her work includes pioneering biomarker profiling for early disease detection and the enhancement of metformin therapy with innovative treatments, like low molecular weight polysaccharides from Astragalus membranaceus. With twelve published journals and ongoing research, her contributions are crucial for improving diabetes management and treatment outcomes in China and potentially worldwide. 📊🔬💊🌍